DAEHAN NEW PHARM CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 054670 for the last quarter is 54.14 B KRW, and it's 12.18% higher compared to the previous quarter. The net income of Q2 24 is 5.60 B KRW.